<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Physiol</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Physiol. (Lond.)</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1469-7793</journal-id>
<journal-id journal-id-type="publisher-id">TJP</journal-id>
<journal-id journal-id-type="hwp">jphysiol</journal-id>
<journal-title-group>
<journal-title>The Journal of Physiology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-3751</issn>
<issn pub-type="epub">1469-7793</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26541360</article-id>
<article-id pub-id-type="pmc">4704499</article-id>
<article-id pub-id-type="doi">10.1113/JP271317</article-id>
<article-id pub-id-type="publisher-id">TJP6940</article-id>
<article-categories>
<subj-group subj-group-type="article-subject-classification">
<subject>Cellular and Molecular Neuroscience</subject>
</subj-group>
<subj-group subj-group-type="article-subject-classification">
<subject>Neurological Conditions, Disorders and Treatments</subject>
</subj-group>
<subj-group subj-group-type="overline">
<subject>Research Paper</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Neuroscience: Cellular/Molecular</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Aberrant regulation of synchronous network activity by the attention‐deficit/hyperactivity disorder‐associated human dopamine D4 receptor variant D4.7 in the prefrontal cortex</article-title>
<alt-title alt-title-type="left-running-head">P. Zhong and others</alt-title>
<alt-title alt-title-type="right-running-head">Aberrant regulation of PFC synchronous network activity</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="tjp6940-cr-0001">
<name>
<surname>Zhong</surname>
<given-names>Ping</given-names>
</name>
<xref ref-type="aff" rid="tjp6940-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="tjp6940-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp6940-cr-0002">
<name>
<surname>Liu</surname>
<given-names>Wenhua</given-names>
</name>
<xref ref-type="aff" rid="tjp6940-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="tjp6940-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="tjp6940-cr-0003">
<name>
<surname>Yan</surname>
<given-names>Zhen</given-names>
</name>
<xref ref-type="aff" rid="tjp6940-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="tjp6940-aff-0002">
<sup>2</sup>
</xref>
</contrib>
</contrib-group>
<aff id="tjp6940-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Physiology &amp; Biophysics, State University of New York at Buffalo</named-content>
<institution>School of Medicine and Biomedical Sciences</institution>
<named-content content-type="city">Buffalo</named-content>
<named-content content-type="country-part">NY</named-content>
<country country="US">USA</country>
</aff>
<aff id="tjp6940-aff-0002">
<label>
<sup>2</sup>
</label>
<institution>VA Western New York Healthcare System</institution>
<named-content content-type="city">Buffalo</named-content>
<named-content content-type="country-part">NY</named-content>
<country country="US">USA</country>
</aff>
<aff id="tjp6940-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">School of Lifescience</named-content>
<institution>Zhaoqing University</institution>
<named-content content-type="city">Zhaoqing</named-content>
<country country="CN">China</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Corresponding author</bold> Z. Yan: Department of Physiology and Biophysics, State University of New York at Buffalo, 124 Sherman Hall, Buffalo, NY 14214, USA. Email: <email>zhenyan@buffalo.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>14</day>
<month>12</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub">
<day>01</day>
<month>1</month>
<year>2016</year>
</pub-date>
<volume>594</volume>
<issue>1</issue>
<issue-id pub-id-type="doi">10.1113/tjp.2016.594.issue-1</issue-id>
<fpage>135</fpage>
<lpage>147</lpage>
<history>
<date date-type="received">
<day>17</day>
<month>7</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>10</month>
<year>2015</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Journal compilation &#x000a9; 2016 The Physiological Society <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2015 The Authors. The Journal of Physiology © 2015 The Physiological Society</copyright-statement>
</permissions>
<self-uri content-type="pdf" xlink:href="file:TJP-594-135.pdf" xlink:type="simple"></self-uri>
<abstract abstract-type="main">
<sec id="tjp6940-sec-0010">
<title>Key points</title>
<p>
<list id="tjp6940-list-0001" list-type="bullet"><list-item><p>The hD4.7 variant has been linked to attention‐deficit/hyperactivity disorder (ADHD); however, the underlying mechanism is unknown.</p></list-item><list-item><p>We found that activation of hD4.7 induced over‐suppression of glutamatergic excitatory network bursts and under‐suppression of GABAergic inhibitory network bursts in the prefrontal cortex (PFC) circuitry.</p></list-item><list-item><p>Methylphenidate, a psychostimulant drug used to treat ADHD, normalized the effects of hD4.7 on synchronous network bursts in PFC pyramidal neurons.</p></list-item><list-item><p>The findings of the present study suggest that the aberrant regulation of PFC synchronous network activity by hD4.7 may underlie its involvement in ADHD.</p></list-item></list>
</p>
</sec>
<sec id="tjp6940-sec-0020">
<title>Abstract</title>
<p>A unique feature of the human D<sub>4</sub> receptor (hD<sub>4</sub>R) gene is the existence of a large number of polymorphisms in exon 3 coding for the third intracellular loop, which consists of a variable number of tandem repeats. The hD<sub>4</sub>R variants with long repeats have been linked to attention‐deficit/hyperactivity disorder (ADHD); however, the underlying mechanism is unknown. Emerging evidence suggests that selective attention is controlled by the rhythmic synchronization in the prefrontal cortex (PFC) and its connected networks. In the present study, we examined the role of hD<sub>4</sub>R variants in regulating PFC synchronous network activity. D<sub>4</sub>R knockout mice with viral infection of hD4.4 or hD4.7 in the medial PFC were used. Whole‐cell patch‐clamp recordings were performed to examine the effects of activating hD4.x on the spontaneous large scale correlated activity in PFC pyramidal neurons. We found that, compared to the normal four‐repeat variant hD4.4, the ADHD‐linked variant hD4.7 induces more suppression of glutamatergic excitatory network bursts and less suppression of GABAergic inhibitory network bursts in the PFC circuitry. Methylphenidate, a psychostimulant drug used to treat ADHD, normalized the effects of hD4.7 on synchronous network bursts in PFC pyramidal neurons. These results reveal the differential effects of hD<sub>4</sub>R variants on the integrated excitability of PFC circuits. It is suggested that the aberrant regulation of PFC network activity by hD4.7 may underlie its involvement in ADHD. The methylphenidate‐induced normalization of synaptic circuitry regulation may contribute to its effectiveness in ADHD treatment.</p>
</sec>
</abstract>
<abstract abstract-type="short">
<title>Key points</title>
<p>
<list id="tjp6940-list-0002" list-type="bullet"><list-item><p>The hD4.7 variant has been linked to attention‐deficit/hyperactivity disorder (ADHD); however, the underlying mechanism is unknown.</p></list-item><list-item><p>We found that activation of hD4.7 induced over‐suppression of glutamatergic excitatory network bursts and under‐suppression of GABAergic inhibitory network bursts in the prefrontal cortex (PFC) circuitry.</p></list-item><list-item><p>Methylphenidate, a psychostimulant drug used to treat ADHD, normalized the effects of hD4.7 on synchronous network bursts in PFC pyramidal neurons.</p></list-item><list-item><p>The findings of the present study suggest that the aberrant regulation of PFC synchronous network activity by hD4.7 may underlie its involvement in ADHD.</p></list-item></list>
</p>
</abstract>
<counts>
<page-count count="13"></page-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>tjp6940</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>1 January 2016</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.7.5 mode:remove_FC converted:22.01.2016</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>